Figure 3From: Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II studyLocal recurrence rates by clinical T stage (panels a) and pCR or not (panels b). pCR: pathological complete response.Back to article page